Gregory Lane
About Gregory Lane
Gregory Lane is a Senior Research Investigator at Bristol-Myers Squibb in New Brunswick, New Jersey, specializing in Process Analytical Technology and bioprocess development.
Company
Gregory Lane is currently working as a Senior Research Investigator at Bristol-Myers Squibb in New Brunswick, New Jersey. Previously, he served as a Research Investigator at the same company from 2000 to 2004, accumulating extensive experience and knowledge within the organization.
Title
As a Senior Research Investigator, Gregory Lane is responsible for overseeing various research projects and innovations at Bristol-Myers Squibb. His role involves managing process operations and incorporating advanced analytical techniques to improve bioprocess development and protein drug product formulation.
Education and Expertise
Gregory Lane has a robust academic background in Chemistry and Organic Chemistry. He earned a BA in Chemistry from Middlebury College (1988-1992), followed by a PhD in Organic Chemistry from Indiana University Bloomington (1992-1997). He continued his education with further studies in Organic Chemistry at the University of Michigan (1997-1999). His expertise spans Process Analytical Technology (PAT), particle sizing techniques, and protein analysis, utilizing tools like ReactIR, Malvern Zetasizer, and Chemglass Reactor Systems.
Background
Gregory Lane has been with Bristol-Myers Squibb since 2000, transitioning from a Research Investigator role to a Senior Research Investigator. His industry background includes significant contributions to adopting jacketed chemical reactors and advancing Process Analytical Technology (PAT). He handles capital planning, manages process operations, and oversees pilot plant equipment, ensuring compliance in cGMP environments.
Achievements
Gregory Lane's work includes developing jacketed chemical reactors, contributing significantly to both the organization and the industry. He is responsible for the IQ/OQ of over 15 pilot plant instruments, integrating PAT into bioprocessing and chemical reactors, and adopting Malvern particle sizing techniques by Process R&D. Additionally, he uses software for multivariate analysis and model building, enhancing the efficacy of research and production processes at Bristol-Myers Squibb.